Noble, John Matthew B.

HRN: 21-41-69  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2022
CEFUROXIME 750MG (VIAL)
06/01/2022
06/07/2022
IV
750mg Ld, Then 375mg
Q8h
Supracondylar Fracture
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Bone & Joint    Compliance to guidelines: Non-compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: